Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Global X Genomics & Biotechnology ETF - USD (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. XHS is down -1.55% year-to-date (YTD) with +$6M in YTD flows. GNOM performs better with -0.14% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of XHS and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XHS GNOM | -0.71%-1.95% | -2.04%-2.77% | -1.55%-0.14% | +11.15%+31.18% | +26.55%-2.20% | +1.67%-49.04% |
| Flows | XHS GNOM | -$8M- | +$2M-$4M | +$6M-$2M | -$3M-$19M | -$36M-$115M | -$38M+$13M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XHS GNOM | +17.76%+23.39% | +19.20%+30.06% | +18.15%+28.58% | +21.13%+33.54% |
| Max drawdown | XHS GNOM | -5.98%-10.49% | -12.54%-22.14% | -17.78%-46.50% | -32.53%-72.17% |
| Max drawdown duration | XHS GNOM | 63d47d | 128d113d | 362d1030d | 1716d1713d |
XHS | GNOM | |
Last sale 3/11/2026 at 1:30 PM | $104.90 | $45.00 |
| Previous close 03/10/2026 | $105.14 | $45.33 |
| Consolidated volume 03/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XHS | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XHS | GNOM | |
|---|---|---|
| Last price | $104.90 | $45.00 |
| 1D performance | -0.23% | -0.74% |
| AuM | $87.35 M | $49.78 M |
| E/R | 0.35% | 0.5% |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
